| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/30/2006 | US7052674 Prokineticin polypeptides, related compositions and methods |
| 05/30/2006 | CA2285450C Regulatory element for expressing genes in plants |
| 05/30/2006 | CA2005311C Prototype felv isolates for use in disease models and vaccines |
| 05/29/2006 | CA2526684A1 Therapeutic peptides and method |
| 05/26/2006 | WO2006055927A2 Pathogenic gene and protein associated with paroxysmal dyskinesia and epilepsy |
| 05/26/2006 | WO2006055665A2 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 05/26/2006 | WO2006055631A2 Casein kinase stress-related polypeptides and methods of use in plants |
| 05/26/2006 | WO2006055623A2 Method and compositions for prevention and treatment of malaria infections |
| 05/26/2006 | WO2006055331A2 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 05/26/2006 | WO2006055004A1 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 05/26/2006 | WO2006054961A2 Novel composition and methods for the treatment of immune related diseases |
| 05/26/2006 | WO2006054798A1 Reagent containing oxygen isotope-labeled hemoglobin for examining vital tissue and method of producing the same |
| 05/26/2006 | WO2006054666A1 Chick lif protein and utilization thereof |
| 05/26/2006 | WO2006054600A1 Novel protein and preventive/remedy for neurodegenerative disease such as polyglutamine disease using the same |
| 05/26/2006 | WO2006054371A1 Novel ion channel-like polypeptide and use thereof |
| 05/26/2006 | WO2006054310A1 Activated labeling reagents and methods for preparing and using the same |
| 05/26/2006 | WO2006054297A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 05/26/2006 | WO2006054281A1 Compositions containing beta 2-glycoprotein i for the prevention and/or treatment of vascular disease |
| 05/26/2006 | WO2006054278A2 Variants of pigment epithelium derived factor and uses thereof |
| 05/26/2006 | WO2006054277A2 Treatment of neurodegenerative disease with angiogenin and its mutants |
| 05/26/2006 | WO2006054138A1 PEPTIDE ABLE TO BREAK THE m-p53/p63, m-p53/ p73 AND m-p53/RESPECTIVE ISOFORM PROTEINS COMPLEX FORMED IN THE TUMOR CELLS AND USES THEREOF IN THE PHARMACOLOGICAL FIELD |
| 05/26/2006 | WO2006054096A2 Soluble bifunctional proteins |
| 05/26/2006 | WO2006054059A1 Neutralising antibody molecules having specificity for human il-17 |
| 05/26/2006 | WO2006053788A2 Alterations in seborrheic keratoses and their applications |
| 05/26/2006 | WO2006053787A1 A non-human animal alzheimer’s disease model and uses thereof |
| 05/26/2006 | WO2006053743A2 Arabidopsis and brassica nucleic acid sequences conferring lipid and sugar alterations in plants and methods of use |
| 05/26/2006 | WO2006053568A1 Tnf antagonists |
| 05/26/2006 | WO2006053565A2 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 05/26/2006 | WO2006053508A1 Immunotherapeutic formulations with interleukin-2-neutralising capacity |
| 05/26/2006 | WO2006053473A1 A bacillus thuringiensis and genes with high larvicidal activity to coleopterans |
| 05/26/2006 | WO2006053439A1 Hcv f protein and uses thereof |
| 05/26/2006 | WO2006027117A3 Diagnostics and therapeutics for diseases associated with cysteinyl leukotriene receptor 2 (cyslt2) |
| 05/26/2006 | WO2006014287A8 Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions |
| 05/26/2006 | WO2006008760A3 A method of diagnosing tuberculosis |
| 05/26/2006 | WO2006008759A3 Antigenic peptides |
| 05/26/2006 | WO2006004660A3 Detection of mutations in a gene associated with resistance to viral infection |
| 05/26/2006 | WO2005119251A3 Novel means and methods for the treatment of hearing loss and phantom hearing |
| 05/26/2006 | WO2005118634A3 Helical peptidomimetics with enhanced activity against beta-amyloid production |
| 05/26/2006 | WO2005116658A3 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 05/26/2006 | WO2005116657A3 Identification of ergothioneine transporter and therapeutic uses thereof |
| 05/26/2006 | WO2005115478A3 Methods and compositions for autism spectrum disorders |
| 05/26/2006 | WO2005115174A3 Alpha-msh-antagonist didpeptide conjugates |
| 05/26/2006 | WO2005112619A3 Novel gene disruptions, compositions and methods relating thereto |
| 05/26/2006 | WO2005111066A3 Polypeptides from non-typeable haemophilus influenzae |
| 05/26/2006 | WO2005104836A3 Drosophila models for diseases affecting learning and memory |
| 05/26/2006 | WO2005100383A3 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 05/26/2006 | WO2005089812A3 Novel antibiotic alternatives |
| 05/26/2006 | WO2005081743A3 Membrane scaffold proteins |
| 05/26/2006 | WO2004091534A3 Inhibitors of n ethylmaleimide sensitive factor |
| 05/26/2006 | WO2004074459A3 Pten-deficient cells and their uses |
| 05/26/2006 | WO2003100007A3 Eta-1 gene and methods for use |
| 05/26/2006 | CA2838516A1 Treatment of disease |
| 05/26/2006 | CA2588765A1 Treatment of neurodegenerative disease with angiogenin and its mutants |
| 05/26/2006 | CA2588573A1 Immunotherapeutic formulations to generate autoantibodies capable to avoid the binding of interleukin-2 to its receptor their use in the treatment of cancer |
| 05/26/2006 | CA2588564A1 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 05/26/2006 | CA2588066A1 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 05/26/2006 | CA2587948A1 Tnf antagonists |
| 05/26/2006 | CA2587921A1 Mutated netrin-4, fragments thereof and their use as medicines |
| 05/26/2006 | CA2587849A1 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 05/26/2006 | CA2587716A1 Hcv f protein and uses thereof |
| 05/26/2006 | CA2587627A1 Desacyl ghrelin antibodies and therapeutic uses thereof |
| 05/26/2006 | CA2587401A1 Casein kinase stress-related polypeptides and methods of use in plants |
| 05/26/2006 | CA2586615A1 Pro87299 (btla), and variants thereof, for treating immune related disorders |
| 05/26/2006 | CA2586331A1 Arabidopsis and brassica nucleic acid sequences conferring lipid and sugar alterations in plants and methods of use |
| 05/26/2006 | CA2586130A1 Reagent containing oxygen isotope-labeled hemoglobin for examining vital tissue and method of producing the same |
| 05/26/2006 | CA2585308A1 A non-human animal alzheimer's disease model and uses thereof |
| 05/26/2006 | CA2584222A1 Neutralising antibody molecules having specificity for human il-17 |
| 05/25/2006 | WO2006037038A9 Optimized vaccines to provide protection against ebola and other viruses |
| 05/25/2006 | WO2006026184A9 Blood brain barrier permeation peptides |
| 05/25/2006 | WO2005111622A9 Diagnostic assay for trypanosoma cruzi infection |
| 05/25/2006 | US20060112454 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 05/25/2006 | US20060112449 Novel B-type gene from oil palm |
| 05/25/2006 | US20060112447 Nucleotide sequences encoding cry1bb proteins for enhanced expression in plants |
| 05/25/2006 | US20060112446 Transposon genes of rice, transformed plant and method of use |
| 05/25/2006 | US20060112443 increasing the weight percent of at least one amino acid essential to the diet of animals, or increasing the starch content of a plant; increased seed storage proteins; stably transforming cells of a plant with an expression cassette |
| 05/25/2006 | US20060112441 CYT28 serpentine receptor disruptions, compositions and methods relating thereto |
| 05/25/2006 | US20060112440 Fluorescent protein sensors for detection of analytes |
| 05/25/2006 | US20060112439 Delta opioid receptor disruptions, compositions and methods related thereto |
| 05/25/2006 | US20060112437 Transgenic animal expressing alzheimer's tau protein |
| 05/25/2006 | US20060111562 Human SDF-5 protein and compositions |
| 05/25/2006 | US20060111561 Novel proteins and nucleic acids encoded thereby |
| 05/25/2006 | US20060111559 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 05/25/2006 | US20060111558 Recombinant infectious laryngotracheitis virus and uses thereof |
| 05/25/2006 | US20060111557 Water soluble toxin produced by pfiesteria species |
| 05/25/2006 | US20060111556 Preventives/remedies for neurodegenerative diseases |
| 05/25/2006 | US20060111555 Protein crystallisation method |
| 05/25/2006 | US20060111554 Method, computing routine, device for predicting properties of mhc/peptide complexes, and data and peptides produced therefrom |
| 05/25/2006 | US20060111552 Metal binding precursors for the synthesis of peptide-metal conjugates |
| 05/25/2006 | US20060111551 Peptide having HTLV-1-specific CTL-inducing activity |
| 05/25/2006 | US20060111315 Method for inhibition of pathogenic microorganisms |
| 05/25/2006 | US20060111313 modulating calvarial osteoblast differentiation and mineralization in human by altering expression or activity of Nell-1 in human, wherein increased expression or activity of Nell-1 increases osteoblast differentiation or mineralization and decreased expression decreases osteoblast differentiation |
| 05/25/2006 | US20060111301 Methods for preventing and treating alzheimer's disease |
| 05/25/2006 | US20060111299 Compositions and methods for treating atherosclerosis |
| 05/25/2006 | US20060111298 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 05/25/2006 | US20060111297 Blood factor domains |
| 05/25/2006 | US20060111293 Antagonists for human prolactin |
| 05/25/2006 | US20060111289 Compositions and methods of using Alpha-fetoprotein growth inhibitory peptides |
| 05/25/2006 | US20060111287 Acetylated protein |
| 05/25/2006 | US20060111282 for treatment of blood coaggulation disorders; trauma |
| 05/25/2006 | US20060111281 Melanocortin receptor-specific |